Short-Chain Fatty Acids Alleviate Perioperative Neurocognitive Disorders Through BDNF/PI3K/Akt Pathway in Middle-Aged Rats
- PMID: 40301246
- DOI: 10.1007/s12035-025-04964-9
Short-Chain Fatty Acids Alleviate Perioperative Neurocognitive Disorders Through BDNF/PI3K/Akt Pathway in Middle-Aged Rats
Abstract
Perioperative neurocognitive disorders (PND), characterized by persistent cognitive impairment lasting from days to years, present substantial clinical challenges in elderly surgical populations, profoundly compromising functional independence, quality of life, and long-term prognosis. We aimed to investigate the effects of short-chain fatty acids (SCFAs) treatment on PND via mediating Brain-derived neurotrophic factor (BDNF)/Phosphatidylinositol3-kinase (PI3K)/Protein kinase B (Akt) pathway. Using 16S rDNA sequencing targeting the V3-V4 hypervariable regions, we first demonstrated significant gut microbiota dysbiosis in PND model rats, accompanied by altered SCFAs profiles. Subsequent fecal microbiota transplantation (FMT) experiments established causal relationships between PND-associated microbial alterations and spatial cognitive deficits. Mechanistically, SCFAs supplementation attenuated neuronal damage and restored synaptic plasticity, as evidenced by Nissl staining quantification (reduced chromatolysis), TUNEL assay (decreased apoptosis rate), and immunohistochemical analysis (upregulated NeuN expression). Molecular investigations revealed that SCFAs-mediated cognitive improvement involved BDNF upregulation and subsequent PI3K/Akt pathway activation, ultimately enhancing neuronal survival and synaptic integrity. Notably, PND animals exhibited characteristic neuropathological features including synaptic density reduction (PSD-95 downregulation), neuroinflammation amplification (IL-6 elevation), and apoptosis activation-all significantly reversed by SCFA intervention. Our findings establish a novel gut-brain axis mechanism wherein microbiota-derived SCFAs may exert neuroprotection through BDNF-dependent PI3K/Akt signaling, and offer potential therapeutic strategies for PND management.
Keywords: Behavioral therapies, cognitive; Brain-derived neurotrophic factor; Cognitive complication, postoperative; Gut microbiome; Neuronal outgrowth.
© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Competing Interests: The authors declare no competing interests.
References
-
- Khachaturian AS, Hayden KM, Devlin JW (2020) International drive to illuminate delirium: a developing public health blueprint for action. Alzheimers Dement 16:711–725. https://doi.org/10.1002/alz.12075 - DOI - PubMed
-
- Boone MD, Sites B, von Recklinghausen FM (2020) Economic burden of postoperative neurocognitive disorders among US Medicare patients. JAMA Netw Open 3:e208931. https://doi.org/10.1001/jamanetworkopen.2020.8931 - DOI - PubMed - PMC
-
- Lin X, Chen Y, Zhang P (2020) The potential mechanism of postoperative cognitive dysfunction in older people. Exp Gerontol 130:110791. https://doi.org/10.1016/j.exger.2019.110791 - DOI - PubMed
-
- Xu H, Chen L, Zhang X, Tian W, Yu W, Wang X, Tian J et al (2019) Central cholinergic neuronal degeneration promotes the development of postoperative cognitive dysfunction. Lab Invest 99:1078–1088. https://doi.org/10.1038/s41374-018-0174-9 - DOI - PubMed
-
- Netto MB, de Oliveira Junior AN, Goldim M (2018) Oxidative stress and mitochondrial dysfunction contributes to postoperative cognitive dysfunction in elderly rats. Brain Behav Immun 73:661–669. https://doi.org/10.1016/j.bbi.2018.07.016 - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
